Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Editorial (Thematic Issue: Antiinflammatory Treatment for Seemingly Non-inflammatory Disorders-Part 2)
Volume: 15 Issue: 3
Author(s): Yoshiro Maru
Affiliation:
Export Options
About this article
Cite this article as:
Maru Yoshiro, Editorial (Thematic Issue: Antiinflammatory Treatment for Seemingly Non-inflammatory Disorders-Part 2), Endocrine, Metabolic & Immune Disorders - Drug Targets 2015; 15 (3) . https://dx.doi.org/10.2174/187153031503150827163933
DOI https://dx.doi.org/10.2174/187153031503150827163933 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
25
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer’s Disease
Current Alzheimer Research Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Risk of Vertical HIV Transmission Combines the ‘B35-Cw4 Disadvantage’ and the ‘Pattern of Inheritance’ Theories of Progression
Current HIV Research Central Blood Pressure and End-organ Damage
Current Hypertension Reviews p53: Fighting Cancer
Current Cancer Drug Targets A Review on the Toxicity and Non-Target Effects of Macrocyclic Lactones in Terrestrial and Aquatic Environments
Current Pharmaceutical Biotechnology Biochemical Strategies to Anticoagulation: A Comparative Overview
Current Vascular Pharmacology Regulation of ABC Transporter Function Via Phosphorylation by Protein Kinases
Current Pharmaceutical Biotechnology A Meta-analysis of Randomized Controlled Trials of the Effect of Probiotic Food or Supplement on Glycemic Response and Body Mass Index in Patients with Type 2 Diabetes, Updating the Evidence
Current Diabetes Reviews Megsin Gene: Its Genomic Analysis, Pathobiological Functions, and Therapeutic Perspectives
Current Genomics Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Endothelial Progenitor Cells (EPCs) Evaluation in Aortic Aneurysm Repair
Current Vascular Pharmacology Remediation of Cellular Hypoxic Damage by Pharmacological Agents
Current Pharmaceutical Design Corticosteroids for the Inflammatory Response to Cardiopulmonary Bypass: An Update
Current Pharmaceutical Design Risk Models and Scores of Cardiovascular Disease in Patients with Diabetes Mellitus
Current Pharmaceutical Design Automated High Content Screening for Phosphoinositide 3 Kinase Inhibition Using an AKT1 Redistribution Assay
Combinatorial Chemistry & High Throughput Screening Phase IV Studies: Some Insights, Clarifications, and Issues
Current Clinical Pharmacology Novel Approaches to Target Pancreatic Cancer
Current Cancer Drug Targets Meet Our Editorial Board Member
Current Tissue Engineering (Discontinued) Endothelial Activation. Sliding Door to Atherosclerosis
Current Pharmaceutical Design The Critical Role of Epigenetic Regulation in Developmental Programming of Higher Organisms
Current Genomics